If you are interested in taking part, talk to your doctor. They may be able to discuss the study with you and talk you through the potential benefits and risks of being involved, before you make your decision about participating.
See if you may take part
All clinical studies have a number of entry criteria that people must meet in order to participate. These are called inclusion and exclusion criteria and are related to a person’s health when they enter the study.
The inclusion and exclusion criteria are there to make sure the group of people included have similar disease characteristics, and to exclude people for whom the study drug might potentially have more risks than benefits.
- Be 18 years of age or older
- Be diagnosed with persistent or chronic primary immune thrombocytopenia (ITP) (i.e. have a diagnosis of primary ITP for at least three months)
- Have a platelet count below 30 (<30x109/L)
- Have received at least one previous treatment for ITP
The exclusion criteria are things that you must NOT have at the start of the study.
- Strong bleeding that needs immediate treatment to balance your platelet levels
- Known hypersensitivity (e.g. being allergic) to any components of the study drug
- Previously or currently diagnosed with a condition called hyperprolinemia
- Relevant active infection, or a serious infection within the last six weeks prior to the first infusion of the study drug
- Known tuberculosis (TB) infection or high risk of getting TB
myOpportunITy will be conducted at study sites around the world.
Find answers to frequently asked questions about the studies to help inform your decision to participate.